Comparison between two soundartists Seth Kim Cohen and Salome Voegelin about the aim of the sounds used in soundart works
2018
0 views
0 downloads
Advisor: Doç. Dr. Ayşegül Güçhan
Abstract (EN)
In my research I would like to focus on two points of view about the value of the sounds used in the works of soundart. But first of all I aimed to present the general development of Sound Art from the first steps to the last works of Soundart today. As to the first point of view, which is supported by the writer and artist Salome Voegelin, soundart requires a mode of listening whose aim is directed to sounds themselves and not the language, context, history, genre, category and such. On the other hand for the artist, musician and critic Seth Kim Cohen, sound art is a practice that inhabits the "extramusical" that investigates relationships, institutions, context, sociality, and history; it eschews sounds-in-themselves as a rejection of the metaphysics of presence. Followingly I am going to discuss these points of view in detail taking into account the conceptual and the perceptual features of soundart.
Author
Asya Canbay
Institution
How to Cite
Asya Canbay (Master Thesis). Comparison between two soundartists Seth Kim Cohen and Salome Voegelin about the aim of the sounds used in soundart works, 2018, Yeditepe University.
License
Tüm Hakları Saklıdır
This work is shared under the specified license terms.
More theses from Yeditepe University
- Studies on cyclodextrin complexation of a poorly water soluble anti-hyperlipidemic drug, tablet formulation and characterization(2021)
- Washington ambassadors in Turkish-US relations (1927-1960)(2023)
- Metamorphosis of female voices: A study of the violation of women in Greek and Roman mythology and feminist rewritings reclaiming the narrative(2022)
- Knowledge distillation with foundation models for image segmentation(2023)
- The relationship between machiavelism, grandiose and vulnerable narcissism, and loneliness among white collar workers(2023)
- Evaluation of drug-drug interaction checkers along clinically relevant adverse drug events in oncology and hematology pediatric patients(2023)